Chronic Pain Affects 100 Million Americans
Pain touches all of us at some point in life; but for millions, it becomes a persistent burden, deeply impacting physical and mental well-being, quality of life, and social and professional relationships.
At EicOsis, we are pioneering a new class of oral treatments that target the root cause of chronic pain, neuroinflammation, a key driver of chronic pain. By inhibiting soluble epoxide hydrolase (sEH), our novel oral treatments reduce inflammation in the central nervous system, addressing pain at its source rather than just masking symptoms. Our mission is to provide safer, more effective solutions for long-term pain relief and improved patient outcomes.
Addressing the Needs of Patients with Pain and Inflammation
At EicOsis, we understand that pain and inflammation are not only physical symptoms: they also affect the quality of life of patients and their loved ones. We are focused on delivering a safe, non-addictive and effective oral treatments.
Current Treatments Have Side Effects and Addiction Potential
Current drugs for those suffering from pain or inflammation leave hundreds of patients without relief and burdened by serious side effects. Pain drugs may cause drowsiness, difficulty focusing, memory loss and a feeling of “brain fog”. Common anti-inflammatories can cause stomach bleeding and have cardiovascular risks. Sometimes, the only drugs that help are opioids, which have a risk of addiction and overdose.
Learn About EicOsis New Approach to Pain and Inflammation Relief
We are developing a novel approach that increases naturally occurring pain-relieving and anti-inflammatory compounds. We aim to alleviate pain and inflammation without the adverse side effects that occur with current treatments.
Patient Resources
Chronic pain is physically and psychologically stressful and can be very hard for you and your loved ones. Find support and reach out to others.
